Overexpression of the c-erbB-2 protein in human breast tumor cell lines
The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
The c‐erbB‐2 proto‐oncogene is amplified in a high percentage of primary human breast tumors, suggesting that the overexpression of this gene may be involved in the development of human breast cancer. We have investigated five human breast tumor cell lines and have detected amplified c‐erbB‐2 gene copies in two of them. This amplification leads to overexpression of the c‐erbB‐2 protein. In addition, two other cell lines have elevated protein levels without gene amplification, suggesting that other mechanisms can lead to overexpression of the c‐erbB‐2 protein. These results are similar to those that we obtained during a study of primary breast tumors (Berger et al.: Cancer Res 48:1238–1243, 1988). These breast tumor cell lines should be useful for an analysis of c‐erbB‐2 expression and of the mechanisms that in some cases lead to overexpression.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Analysis of the SK-BR-3 gDNA identified high levels of HER2 amplification that corresponds with the published copy number range (14–24 copies per diploid genome) (41,43–45,47).”
From Comparison of microfluidic digital PCR and conventional quantitative PCR for measuring copy number variation (2012) · cites this paper as [47]
Citations
Cites
Detection of specific sequences among DNA fragments separated by gel electrophoresis
Southern, E. M. (1975) · Journal of Molecular Biology · doi:10.1016/s0022-2836(75)80083-0 · Cited by 32,249
Hsu, S. M., Raine, L., & Fanger, H. (1981) · Journal of Histochemistry & Cytochemistry · doi:10.1177/29.4.6166661 · Cited by 14,140
Slamon, D. J., Clark, G. M., Wong, S. G., Levin, W. J., Ullrich, A., & McGuire, W. L. (1987) · Science · doi:10.1126/science.3798106 · Cited by 11,760
Carpenter, G., & Cohen, S. (1979) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.48.070179.001205 · Cited by 2,909
Close similarity of epidermal growth factor receptor and v-erb-B oncogene protein sequences
Downward, J., Yarden, Y., Mayes, E., Scrace, G., Totty, N., Stockwell, P., Ullrich, A., Schlessinger, J., & Waterfield, M. D. (1984) · Nature · doi:10.1038/307521a0 · Cited by 2,516
Amplification of N- myc in Untreated Human Neuroblastomas Correlates with Advanced Disease Stage
Brodeur, G. M., Seeger, R. C., Schwab, M., Varmus, H. E., & Bishop, J. M. (1984) · Science · doi:10.1126/science.6719137 · Cited by 2,262
Ribonucleic acid isolated by cesium chloride centrifugation
Glisin, V., Crkvenjakov, R., & Byus, C. (1974) · Biochemistry · doi:10.1021/bi00709a025 · Cited by 2,156
Coussens, L., Yang-Feng, T. L., Liao, Y.-C., Chen, E., Gray, A., McGrath, J., Seeburg, P. H., Libermann, T. A., Schlessinger, J., Francke, U., et al. (1985) · Science · doi:10.1126/science.2999974 · Cited by 1,814
The Molecular Genetics of Cancer
Bishop, J. M. (1987) · Science · doi:10.1126/science.3541204 · Cited by 1,688
Similarity of protein encoded by the human c-erb-B-2 gene to epidermal growth factor receptor
Yamamoto, T., Ikawa, S., Akiyama, T., Semba, K., Nomura, N., Miyajima, N., Saito, T., & Toyoshima, K. (1986) · Nature · doi:10.1038/319230a0 · Cited by 1,204
The neu oncogene: an erb-B-related gene encoding a 185,000-Mr tumour antigen
Schechter, A. L., Stern, D. F., Vaidyanathan, L., Decker, S. J., Drebin, J. A., Greene, M. I., & Weinberg, R. A. (1984) · Nature · doi:10.1038/312513a0 · Cited by 1,175
Amplification of a Novel v- erb B-Related Gene in a Human Mammary Carcinoma
King, C. R., Kraus, M. H., & Aaronson, S. A. (1985) · Science · doi:10.1126/science.2992089 · Cited by 1,072
erb B-2 Is a Potent Oncogene When Overexpressed in NIH/3T3 Cells
Di Fiore, P. P., Pierce, J. H., Kraus, M. H., Segatto, O., King, C. R., & Aaronson, S. A. (1987) · Science · doi:10.1126/science.2885917 · Cited by 1,010
Hudziak, R. M., Schlessinger, J., & Ullrich, A. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.20.7159 · Cited by 625
Kraus, M. H., Popescu, N. C., Amsbaugh, S. C., & King, C. R. (1987) · The EMBO Journal · doi:10.1002/j.1460-2075.1987.tb04797.x · Cited by 617
Berger, M. S., Locher, G. W., Saurer, S., Gullick, W. J., Waterfield, M. D., Groner, B., & Hynes, N. E. (1988) · PubMed · Cited by 611
Self-citationSemba, K., Kamata, N., Toyoshima, K., & Yamamoto, T. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.19.6497 · Cited by 598
Venter, D., Kumar, S., Tuzi, N., & Gullick, W. (1987) · The Lancet · doi:10.1016/s0140-6736(87)92736-x · Cited by 404
Drebin, J. A., Link, V. C., Stern, D. F., Weinberg, R. A., & Greene, M. I. (1985) · Cell · doi:10.1016/s0092-8674(85)80050-7 · Cited by 400
Oncogene Amplification in Tumor Cells
(1986) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60201-8 · Cited by 346
van de Vijver, M., van de Bersselaar, R., Devilee, P., Cornelisse, C., Peterse, J., & Nusse, R. (1987) · Molecular and Cellular Biology · doi:10.1128/mcb.7.5.2019 · Cited by 330
Semba, K. (1985) · Medical Entomology and Zoology · Cited by 214
Expression of the c‐erb B‐2 protein in normal and transformed cells
Gullick, W. J., Berger, M. S., Bennett, P. L. P., Rothbard, J. B., & Waterfield, M. D. (1987) · International Journal of Cancer · doi:10.1002/ijc.2910400221 · Cited by 197
Characterization of the promoter region of the human c-erbB-2 protooncogene.
Ishii, S., Imamoto, F., Yamanashi, Y., Toyoshima, K., & Yamamoto, T. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.13.4374 · Cited by 86
Human HER2 (neu) promoter: evidence for multiple mechanisms for transcriptional initiation.
Tal, M., King, C. R., Kraus, M. H., Ullrich, A., Schlessinger, J., & Givol, D. (1987) · Molecular and Cellular Biology · doi:10.1128/mcb.7.7.2597 · Cited by 74
Kozma, S. C., Redmond, S. M. S., Fu, X., Saurer, S., Groner, B., & Hynes, N. E. (1988) · The EMBO Journal · doi:10.1002/j.1460-2075.1988.tb02794.x · Cited by 68
Self-citationSm, R., Ernst Reichmann, A., Rg, M., Friis, R. R., Groner, B., & Ne, H. (1988) · PubMed · Cited by 56
Self-citationCharacterization of the promoter region of the human c-erb B-2 proto-oncogene
Oshii, S. (1987) · Medical Entomology and Zoology · Cited by 25
Research works printed but not linked: 2
- Berger MS, 1988, Cancer Res, 48, 1238
- Redmond SMS, 1988, Oncogene, 2, 259
Cited by
Graus-Porta, D. (1997) · The EMBO Journal · doi:10.1093/emboj/16.7.1647 · Cited by 1,590
“21N (Hynes et al., 1989), ErbB-3-specific affinity purified rabbit polyHowever, the presence of ErbB-2 dramatically enhances clonal antibody C17 (Santa Cruz Biotechnology), ErbB-4-specific mAb transactivation of NDF receptors by ErbB-1, demonstrating 111 (Chen et al., 1996), ErbB-4-specific…”
BackgroundSelf-citationSeidman, A. D., Fornier, M. N., Esteva, F. J., Tan, L., Kaptain, S., Bach, A., Panageas, K. S., Arroyo, C., Valero, V., Currie, V., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.10.2587 · Cited by 547
Pegram, M. D., Konecny, G. E., O'Callaghan, C., Beryt, M., Pietras, R., & Slamon, D. J. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh131 · Cited by 512
“Multiple drug effect analysis was performed using four HER2-overexpressing cell lines ( 23 ,24).”
MethodDifferential responses of human tumor cell lines to anti-p185HER2 monoclonal antibodies
Lewis, G. D., Figari, I., Fendly, B., Lee Wong, W., Carter, P., Gorman, C., & Shepard, H. M. (1993) · Cancer Immunology, Immunotherapy · doi:10.1007/bf01518520 · Cited by 498
“Amplification and overexpression of HER2 are found frequently in breast-tumor-derived cell lines [25, 30, 31] and in human mammary carcinomas [6, 61-63].”
BackgroundWhale, A. S., Huggett, J. F., Cowen, S., Speirs, V., Shaw, J., Ellison, S., Foy, C. A., & Scott, D. J. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks203 · Cited by 453
Metadata
- Authors
- Hynes, N. E., Gerber, H. A., Saurer, S., & Groner, B.
- Affiliations
- University Hospital of Bern (CH)
- University of Bern (CH)
- ORCID
- Hynes, Nancy E.
- Venue
- Journal of Cellular Biochemistry
- Publisher
- Wiley
- Published
- 1989-02
- Volume
- 39
- Issue
- 2
- Pages
- 167-173
- ISSN
- 0730-2312 (ISSN-L)
- 1097-4644
- OpenAlex
- W2060531515
- Cited by
- 109
- References
- 28
- Citations by year
- 2026: 1 · 2023: 1 · 2018: 1 · 2017: 2 · 2015: 1 · 2014: 2 · 2013: 2 · 2012: 3
- FWCI
- 1.56
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Cellular Biochemistry (publishedVersion)
- PubMed (publishedVersion)
- Funders
- University of Pennsylvania
- Topics
- Health Sciences › Medicine › Oncology › HER2/EGFR in Cancer Research
- Health Sciences › Medicine › Pathology and Forensic Medicine › Breast Lesions and Carcinomas
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Breast Cancer Treatment Studies
- Keywords
- c-erbB-2, HER2/neu, gene amplification, protein overexpression, breast cancer, breast cancer cell lines, proto-oncogenes
- MeSH terms
- Proto-Oncogene Mas, Breast Neoplasms, DNA, Neoplasm, Gene Amplification, Nucleic Acid Hybridization, Proto-Oncogene Proteins, RNA, Neoplasm, Tumor Cells, Cultured, Blotting, Southern, Receptor, ErbB-2, Erb-b2 Receptor Tyrosine Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.